COATS LONNEL has filed 29 insider transactions across 3 companies since February 2023.
Most recent transaction: a grant/award of 207931 shares of Relay Therapeutics, Inc. ($RLAY) on November 04, 2025.
Activity breakdown: 6 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 4, 2025 | Relay Therapeutics, Inc. | $RLAY | COATS LONNEL | Not found | A | Stock Option (Right to Buy) | 207931 | $0.00 | 207,931.0000 | 173,322,385 | 9999.99% | 0.12% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | COATS LONNEL | Not found | D | Stock Option (right to buy) | 136139 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.15% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | COATS LONNEL | Not found | D | Stock Option (right to buy) | 42200 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.05% |
| June 5, 2025 | Verve Therapeutics, Inc. | $VERV | COATS LONNEL | Not found | A | Stock Option (right to buy) | 42200 | $0.00 | 42,200.0000 | 89,143,237 | 9999.99% | 0.05% |
| June 26, 2024 | Verve Therapeutics, Inc. | $VERV | COATS LONNEL | Not found | A | Stock Option (right to buy) | 136139 | $0.00 | 136,139.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | M | Restricted Stock Units | 33333 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | M | Restricted Stock Units | 91364 | $0.00 | 91,363.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | M | Restricted Stock Units | 120383 | $0.00 | 240,767.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | M | Common Stock | 33333 | $0.00 | 947,692.0000 | 0 | 3.65% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | M | Common Stock | 91364 | $0.00 | 1,039,056.0000 | 0 | 9.64% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | M | Common Stock | 120383 | $0.00 | 1,159,439.0000 | 0 | 11.59% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | F | Common Stock | 61371 | $2.62 | 1,098,068.0000 | 0 | 5.29% | 0.00% |
| Feb. 8, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | A | Stock Option (Right to Buy) | 770420 | $0.00 | 770,420.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | A | Restricted Stock Units | 770420 | $0.00 | 770,420.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | P | Common Stock | 90000 | $1.05 | 914,359.0000 | 0 | 10.92% | 0.00% |
| Nov. 10, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | P | Common Stock | 10000 | $1.01 | 824,359.0000 | 0 | 1.23% | 0.00% |
| June 29, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | P | Common Stock | 10000 | $2.16 | 814,359.0000 | 0 | 1.24% | 0.00% |
| June 23, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | P | Common Stock | 10000 | $2.50 | 794,359.0000 | 0 | 1.27% | 0.00% |
| June 26, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | P | Common Stock | 10000 | $2.18 | 804,359.0000 | 0 | 1.26% | 0.00% |
| June 22, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | P | Common Stock | 40000 | $2.31 | 784,359.0000 | 0 | 5.37% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | M | Common Stock | 84630 | $0.00 | 670,633.0000 | 0 | 14.44% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | M | Common Stock | 33334 | $0.00 | 703,967.0000 | 0 | 4.97% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | M | Common Stock | 91363 | $0.00 | 795,330.0000 | 0 | 12.98% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | F | Common Stock | 50971 | $2.17 | 744,359.0000 | 0 | 6.41% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | M | Restricted Stock Units | 84630 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | M | Restricted Stock Units | 33334 | $0.00 | 33,333.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | M | Restricted Stock Units | 91363 | $0.00 | 182,727.0000 | 0 | 33.33% | 0.00% |
| Feb. 9, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | A | Restricted Stock Units | 361150 | $0.00 | 361,150.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | COATS LONNEL | Chief Executive Officer | A | Stock Option (Right to Buy) | 1083440 | $0.00 | 1,083,440.0000 | 0 | 9999.99% | 0.00% |